KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2025)

Fulgent Genetics' Other Non-Current Liabilities history spans 9 years, with the latest figure at $7.6 million for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $7.6 million; the TTM value through Sep 2025 reached $7.6 million, changed N/A, while the annual FY2024 figure was $7.0 million, 53.77% down from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $7.6 million at Fulgent Genetics, up from $7.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $21.7 million in Q2 2022 and bottomed at $474000.0 in Q1 2021.
  • The 5-year median for Other Non-Current Liabilities is $9.7 million (2022), against an average of $9.7 million.
  • The largest annual shift saw Other Non-Current Liabilities skyrocketed 4191.49% in 2022 before it tumbled 54.61% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $6.8 million in 2021, then surged by 167.96% to $18.2 million in 2022, then decreased by 17.28% to $15.1 million in 2023, then crashed by 53.77% to $7.0 million in 2024, then increased by 8.38% to $7.6 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Other Non-Current Liabilities are $7.6 million (Q3 2025), $7.0 million (Q4 2024), and $14.4 million (Q2 2024).